Research Mission Statement

To perform frontier research and transform results into cutting edge products to support drug development

Bayer Technology Services is a subsidiary of the Bayer AG, one of the leading research companies worldwide, annually investing more than EUR 2.5 billion into research and development to utilize science for a better life. In addition to these large investments, BTS is actively participating in publicly funded research projects within the area of computational systems biology. We acknowledge the support and enjoy the partnerships with research institutions, which have developed within these frameworks. Overall, BTS has established fruitful partnerships with many academic institutions and industrial corporations providing a track record for future projects.

Our commitment to frontier research is documented by publications in international scientific journals, poster presentations and talks on conferences, and our software solutions for PBPK and systems biology research. Together with our services, this makes a real difference to support drug development.

Find out more about our

Publicly Funded Projects
Partners
Publications

Quicksearch Quicksearch

April 28, 2010

Metabolic engineering review published: Metabolic flux distributions ...

» More

December 16, 2009

Physiologically-based Modeling of Therapeutic Proteins is now possible with PK-Sim® Version 4.2!

» More

November 13, 2009

Virtual drug tests increase patient safety: The blood simulator

» More

September 09, 2010

Rosenön meeting on Optimizing Drug Delivery to the Target, Stockholm, Sweden, September 9-11

» More

October 15, 2010

11th International Conference on Systems Biology (ICSB), Edinburgh, October 15, 2010

» More